References
- Ellis A, Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 1996;16:379–88.
- Trewby PN, Williams R. Pathophysiology of hypotension in patients with fulminant hepatic failure. Gut 1977;18:1021–6.
- Guyton AC, Hall JE. The circulation. In: Guyton AC, Hall JE, editors. Textbook of medical physiology. Philadelphia: WB Saunders; 2000. p. 161–297.
- Makin AJ, Hughes RD, Williams R. Systemic and hepatic hemodynamic changes in acute liver injury. Am J Physiol 1997; 272:G617–25.
- Wendon JA, Harrison PM, Keays R, Gimson AE, Alexander GJ, Williams R. Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure. Hepatology 1992;15:1067–71.
- Clemmesen JO, Galatius S, Skak C, Dalgaard P, Larsen FS, Ott P. The effect of increasing blood pressure with dopamine on systemic, splanchnic, and lower extremity hemodynamics in patients with acute liver failure. Scand J Gastroenterol 1999;34: 917–27.
- Ytrebo LM, Nedredal GI, Langbakk B, Revhaug A. An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure. Scand J Gastroenterol 2002;37:1077–88.
- Harrison P, Wendon J, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology 1996;23:1067–72.
- Schneider F, Lutun P, Boudjema K, Wolf P, Tempe JD. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology 1994;19:38–44.
- Smith RE, Robinson NM, McPeake JR, Baylis SA, Charles IG, Heaton ND, et al. Induction and role of NO synthase in hypotensive hepatic failure. Arterioscler Thromb Vasc Biol 1997;17: 3079–82.
- Ytrebo LM, Korvald C, Nedredal GI, Elvenes OP, Nielsen Grymyr OJ, Revhaug A. N-acetylcysteine increases cerebral perfusion pressure in pigs with fulminant hepatic failure. Crit Care Med 2001;29:1989–95.
- Ytrebo LM, Ingebrigtsen T, Nedredal GI, Elvenes OP, Korvald C, Romner B, et al. Protein S-100β: a biochemical marker for increased intracranial pressure in pigs with acute hepatic failure. Scand J Gastroenterol 2000;35:546–51.
- Schepke M, Heller J, Paschke S, Thomas J, Wolff M, Neef M, et al. Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism. Hepatology 2001;34:884–8.
- Kushnir Mm, Urry FM, Frank EL, Roberts WL, Shushan B. Analysis of catecholamines in urine by positive-ion electrospray tandem mass spectrometrometry. Clin Chem 2002;48:323–31.
- Tabernero A, Schneider F, Potenza MA, Fidi-Soa Randriamboa-vonjy V, Chasserot S, Wolf P, et al. Cyclooxygenase-2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases: immuno-localization and influence on vascular tone. Intensive Care Med 2003;29: 262–70.
- Helmy A, Newby DE, Jalan R, Johnston NR, Hayes PC, Webb DJ. Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis. J Hepatol 2003;38:44–50.